<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03935763</url>
  </required_header>
  <id_info>
    <org_study_id>DIM-95005-001</org_study_id>
    <nct_id>NCT03935763</nct_id>
  </id_info>
  <brief_title>Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective</brief_title>
  <acronym>PROMETCO</acronym>
  <official_title>A Real World Evidence Prospective Cohort Study in the Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Servier Affaires Médicales</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Servier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Real World Evidence Prospective Cohort Study in the Management of Metastatic Colorectal
      Cancer: A Clinical and Patient Perspective
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 8, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>From date of randomization until the date of death from any cause, assessed up to 24 months months</time_frame>
    <description>metastatic Colorectal Cancer (mCRC) overall survival in real world setting</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease control measured by overall response</measure>
    <time_frame>within 18 months from enrollment</time_frame>
    <description>Overall response to treatment defined by complete and partial response, stable disease, progression of the disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life using Patients Reported Outcomes</measure>
    <time_frame>within 18 months from enrollment</time_frame>
    <description>Patients Reported Outcomes defined by a modified version of the questionnaire ACCEPTance by the Patients of their Treatment (ACCEPT)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Metastatic Colorectal Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observational disease study</intervention_name>
    <description>observation of routine clinical practices in mCRC</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The target population will be adults with mCRC who are eligible and willing to receive
        subsequent treatment, having had two prior progressions since diagnosis of first
        metastasis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18

          -  Diagnosis of mCRC

          -  Having had two disease progressions since diagnosis of first metastasis that led to
             first systemic treatment.

        Exclusion Criteria:

          -  Currently participating in an investigational clinical trial (thus it does not apply
             to observational cohort studies)

          -  Currently being treated for other cancer(s)

          -  Not having mental capacity and/or ability to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Myriam Koopman</last_name>
    <phone>+31 88 75 56263</phone>
    <email>M.Koopman-6@umcutrecht.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto de Oncología Angel H. Roffo</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariano Dioca</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Landeskrankenhaus-Universitaetsklinik</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Greil</last_name>
      <email>r.greil@salk.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Antwerp University Hospital</name>
      <address>
        <city>Edegem</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Peeters</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinicki Bolnicki Centar (KBC) Zagreb</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stjepko Plestina</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital in Hradec Kralove Clinic of Oncology and Radiotherapy</name>
      <address>
        <city>Hradec Králové</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanislav John</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Baptiste Bachet</last_name>
      <phone>01 42 16 10 41</phone>
      <email>jean-baptiste.bachet@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Wolfsburg</name>
      <address>
        <city>Wolfsburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nils Homann</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Of Heraklion</name>
      <address>
        <city>Heraklion</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dimitrios Mavroudis, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Del-Pesti Centrum Korhaz OHII, Szent Laszlo Korhaz Telephely</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gyorgy Bodoky</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Adelaide &amp; Meath Hospital-Dublin Incorporating The National Children's Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Raymond McDermott</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Arcispedale Santa Maria Nuova</name>
      <address>
        <city>Reggio Emilia</city>
        <zip>42123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Chiara Banzi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMC Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myriam Koopman</last_name>
      <phone>+31 88 75 562 65</phone>
      <email>M.Koopman-6@umcutrecht.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Des Estudos Egas Moniz - Hospital Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andre Mansinho</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute Of Oncology Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janja Ocvirk</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rocio Garcia Carbonero</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vasteras Central Hospital</name>
      <address>
        <city>Västerås</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrzej Piwowar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UniversitaetsSpital Zuerich (University Hospital Zurich)</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Siebenhuner</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Research UK, Department of Medical Oncology-The Christie NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisca Marti Marti</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Croatia</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Portugal</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Denmark</country>
  </removed_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 24, 2019</study_first_submitted>
  <study_first_submitted_qc>May 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2019</study_first_posted>
  <last_update_submitted>March 9, 2020</last_update_submitted>
  <last_update_submitted_qc>March 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Real Worl Evidence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

